These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16224050)

  • 21. The genetic determinants of atorvastatin response.
    Rodrigues AC; Hirata MH; Hirata RD
    Curr Opin Mol Ther; 2007 Dec; 9(6):545-53. PubMed ID: 18041665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes.
    Parker BA; Thompson PD
    Exerc Sport Sci Rev; 2012 Oct; 40(4):188-94. PubMed ID: 23000957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional deficits in oxidative phosphorylation with statin myopathy.
    Hubal MJ; Reich KA; De Biase A; Bilbie C; Clarkson PM; Hoffman EP; Thompson PD
    Muscle Nerve; 2011 Sep; 44(3):393-401. PubMed ID: 21996800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Judicious evaluation of adverse drug reactions: inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced muscle injury.
    Dietz BL; Oberg KC
    Pharmacotherapy; 1999 Feb; 19(2):232-5. PubMed ID: 10030775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of statin therapy due to muscular side effects: a survey in real life.
    Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
    Rosenberg L; Uretsky S
    Circulation; 2007 Jul; 116(1):e8; author reply e9. PubMed ID: 17606852
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins].
    Veyrac G; Cellerin L; Jolliet P
    Therapie; 2006; 61(1):57-67. PubMed ID: 16792155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Statin-induced dysphagia].
    Edholm B
    Ugeskr Laeger; 2010 Feb; 172(7):544-5. PubMed ID: 20156405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.
    Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K
    Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression patterns of atrogenic and ubiquitin proteasome component genes with exercise: effect of different loading patterns and repeated exercise bouts.
    Nedergaard A; Vissing K; Overgaard K; Kjaer M; Schjerling P
    J Appl Physiol (1985); 2007 Nov; 103(5):1513-22. PubMed ID: 17690190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
    S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
    [No Abstract]   [Full Text] [Related]  

  • 34. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle.
    Bouitbir J; Singh F; Charles AL; Schlagowski AI; Bonifacio A; Echaniz-Laguna A; Geny B; Krähenbühl S; Zoll J
    Antioxid Redox Signal; 2016 Jan; 24(2):84-98. PubMed ID: 26414931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin-associated exacerbation of myasthenia gravis.
    Cartwright MS; Jeffery DR; Nuss GR; Donofrio PD
    Neurology; 2004 Dec; 63(11):2188. PubMed ID: 15596782
    [No Abstract]   [Full Text] [Related]  

  • 37. Human skeletal muscle drug transporters determine local exposure and toxicity of statins.
    Knauer MJ; Urquhart BL; Meyer zu Schwabedissen HE; Schwarz UI; Lemke CJ; Leake BF; Kim RB; Tirona RG
    Circ Res; 2010 Feb; 106(2):297-306. PubMed ID: 19940267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin-associated myopathy with normal creatine kinase levels.
    Phillips PS; Haas RH; Bannykh S; Hathaway S; Gray NL; Kimura BJ; Vladutiu GD; England JD;
    Ann Intern Med; 2002 Oct; 137(7):581-5. PubMed ID: 12353945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
    Cannon CS
    JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].
    Rubí S; Duch J; Ortín J; Setoain X; Pons F
    Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.